@isofolmedical.com
Isofol is a biotech company developing a new drug candidate for the treatment of advanced colorectal cancer
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
Isofol Medical AB (publ) is a pioneering brand dedicated to enhancing the effectiveness of current standard treatments for colorectal cancer and other tumor diseases. The company is focused on developing the drug candidate arfolitixorin, which has shown promise in increasing the efficacy of existing therapies. Isofol Medical has completed a Phase III study for arfolitixorin and is now evaluating opportunities to move forward with a marketing authorization application by conducting additional studies and exploring potential partnerships.
As colorectal cancer is the third most common form of cancer globally, there is a critical need for more effective treatment options. Isofol Medical AB (publ) is traded on Nasdaq Stockholm, further illustrating its commitment to innovation and growth in the medical field
Company Type
Public Company
Company Size
11-50
Year Founded
2008
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories